Tissue Repair Ltd

As of June 30, 2026, Tissue Repair Ltd carries a market capitalization of 6.05M, placing it among publicly traded companies globally. Its enterprise value stands at 1.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Tissue Repair Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2026, Tissue Repair Ltd has 60.46M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 10.80, and the price-to-book ratio stands at 0.69.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.28 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.28M versus a market cap of 6.05M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Tissue Repair Ltd maintains a current ratio of 6.36, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Tissue Repair Ltd's stock has declined approximately 72.33% over the past 52 weeks. The 50-day moving average sits at 0.09, while the 200-day moving average is 0.19.

Over the twelve months ended June 30, 2026, Tissue Repair Ltd generated 559,702.00 in revenue and converted that into -5.36M in net income, yielding earnings per share of -0.09. EBITDA reached -7.75M, while operating income came in at -7.98M.

These figures are as of June 30, 2026. Total book value stands at 8.77M, with working capital of 8.37M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -1,425.03 and net profit margin of -958.01 provide insight into operational efficiency.

As of June 30, 2026, Tissue Repair Ltd has an Altman Z-Score of -3.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.